Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 May 29;10(2):66.
doi: 10.3390/pharmaceutics10020066.

Review of Intraocular Pharmacokinetics of Anti-Infectives Commonly Used in the Treatment of Infectious Endophthalmitis

Affiliations
Review

Review of Intraocular Pharmacokinetics of Anti-Infectives Commonly Used in the Treatment of Infectious Endophthalmitis

Andrea Luaces-Rodríguez et al. Pharmaceutics. .

Abstract

Although intravitreal administration of anti-infectives represents the standard treatment for infectious endophthalmitis, the knowledge about their pharmacokinetics is still limited. In this review, we aimed to summarise the factors influencing the pharmacokinetics of the anti-infective agents. We have conducted a comprehensive review of the preclinical pharmacokinetic parameters obtained in different studies of intravitreal injections of anti-infectives performed on animals, mainly rabbits. The two aspects with the biggest influence on pharmacokinetics are the distribution in the vitreous humour and the elimination through the posterior segment. The distribution can be affected by the molecular weight of the drug, the convection flow of the vitreous, the condition of the vitreous humour depending on the age of the patient, the possible interactions between the drug and the components of the vitreous, and the presence of vitrectomy. Meanwhile, the elimination includes the metabolism of the drug, the clearance via the anterior and posterior routes, and the possible inflammation of the eye resulting from the disease. Understanding the pharmacokinetics of the anti-infectives used in clinical practice is essential for a correct application. The information provided in this review could offer guidance for selecting the best therapeutic option according to the characteristics of the drugs.

Keywords: anti-infectives; endophthalmitis; infection; intravitreal; pharmacokinetics.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Scheme of the routes of administration of anti-infectives into the eye.

References

    1. Vaziri K., Schwartz S.G., Kishor K., Flynn H.W. Endophthalmitis: State of the art. Clin. Ophthalmol. 2015;9:95–108. - PMC - PubMed
    1. Barry P., Cordovés L., Gardner S. ESCRS Guidelines for Prevention and Treatment of Endophthalmitis Following Cataract Surgery: Data, Dilemmas and Conclusions. The European Society for Cataract and Refractive Surgeons; Dublin, Ireland: 2013.
    1. López-Cabezas C., Muner D.S., Massa M.R., Mensa Pueyo J.M. Antibiotics in endophthalmitis: Microbiological and pharmacokinetic considerations. Curr. Clin. Pharmacol. 2010;5:47–54. doi: 10.2174/157488410790410597. - DOI - PubMed
    1. Radhika M., Mithal K., Bawdekar A., Dave V., Jindal A., Relhan N., Albini T., Pathengay A., Flynn H.W. Pharmacokinetics of intravitreal antibiotics in endophthalmitis. J. Ophthalmic Inflamm. Infect. 2014;4:22. doi: 10.1186/s12348-014-0022-z. - DOI - PMC - PubMed
    1. Barcia M.G. Aspectos Prácticos de la Farmacotécnia en un Servicio de Farmacia. Master Line Prodigio; Galpagar, Spain: 2011. Formulación Magistral en Oftalmología.